Translational Physiologically Based Pharmacokinetic (PBPK) Model for ABL501, an Immuno-Oncology Bispecific Antibody Targeting LAG-3 and PD-L1
Cesar Pichardo-Almarza, Tomomi Matsuura, Andrzej M. Kierzek, Suruchi Bakshi, Eunyoung Park, Piet H. van der Graaf, Jacques Gaudreault, Eunjung Kim, Jaeho Jung, Jonghwa Won |
Oral Presentation